Captopril
Top View
- The Renin-Angiotensin Pathway
- NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
- Angiotensin Converting Enzyme (Ace) Inhibitors
- Renin Inhibition: What Are the Therapeutic Opportunities?
- Pharmaceutical Benefits Scheme Codes
- Effects of Nine Antihypertensive Drugs on Blood Pressure Variability in Sinoaortic-Denervated Rats1
- Kidney and Lung ACE2 Expression After an ACE Inhibitor Or an Ang II Receptor Blocker: Implications for COVID-19
- CAPOTEN® (Captopril Tablets, USP) Rx Only
- Package Leaflet: Information for the Patient Captopril 12.5Mg Tablets
- Reliability of Captopril Renography in Patients Under Chronic Therapy with Angiotensin II (AT1) Receptor Antagonists
- Captopril and Telmisartan Ameliorate Cisplatin-Induced Testicular Damage in Rats Via Anti-Inflammatory and Antioxidant Pathways
- Diabetes and CVD Risk During Angiotensin-Converting Enzyme Inhibitor Or Angiotensin II Receptor Blocker Treatment in Hypertension: a Study of 15 990 Patients
- When Will the ACE-Inhibitors Be Declared Obsolete?
- About Your Medication CAPTOPRIL
- DIOVAN Vs Captopril
- Low Dose Captopril in the Treatment of Severe Refractory Hypertension Associated with Renal Failure G
- Effects of Captopril and Enalapril on Renal Function in Elderly Patients with Chronic Heart Failure
- SPECIAL FEATURE J Am Soc Nephrol 15: 1356–1357, 2004